RenovoRx RNXT
NASDAQ RNXT
$1.77 -0.23 (-11.28%)
At close: Sep 10, 2026 · 4:00 PM EDT

RenovoRx (RNXT) Operating Leases (2024 - 2026)

RenovoRx's (RNXT) quarterly Operating Leases came in at $390000.0 in Q2 2026, up 142.24% year-over-year from $161000.0 in Q2 2025, and up 109.68% quarter-over-quarter from $186000.0 in Q1 2026.

Analysis

RenovoRx (RNXT) Operating Leases (2024 - 2026) Analysis & Trends

RenovoRx has disclosed Operating Leases across 3 years of filings, most recently posting $390000.0 for Q2 2026.

  • In Q2 2026, Operating Leases rose 142.24% year-over-year to $390000.0; the TTM figure through Jun 2026 stood at $390000.0 (up 142.24% YoY), while the FY2025 annual figure was $212000.0, changed 0.0% from the prior year.
  • Operating Leases came in at $390000.0 for Q2 2026 at RenovoRx, up from $186000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $390000.0 in Q2 2026 to a low of $134000.0 in Q3 2025.
  • Average Operating Leases over 3 years is $211571.4, with a median of $186000.0 recorded in 2025.
  • Year-over-year, Operating Leases changed 0.0% in 2025 and jumped 142.24% in 2026.
  • Over 3 years, Operating Leases stood at $212000.0 in 2024, then changed by 0.0% to $212000.0 in 2025, then surged by 83.96% to $390000.0 in 2026.
  • Per Business Quant data, the three most recent Operating Leases figures were $390000.0 in Q2 2026, $186000.0 in Q1 2026, and $212000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn
10 RenovoRx 83.48 Mn 83.48 Mn 766,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 390,000.00
Mar 31, 2026 186,000.00
Dec 31, 2025 212,000.00
Sep 30, 2025 134,000.00
Jun 30, 2025 161,000.00
Mar 31, 2025 186,000.00
Dec 31, 2024 212,000.00